Related references
Note: Only part of the references are listed.PLGA-Based Composites for Various Biomedical Applications
Catia Vieira Rocha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Immunogenic cell stress and death
Guido Kroemer et al.
NATURE IMMUNOLOGY (2022)
Tumor cell-based vaccine: an effective strategy for eradication of cancer cells
Seyed Amir Sadeghi Najafabadi et al.
IMMUNOTHERAPY (2022)
Targeting inorganic nanoparticles to tumors using biological membrane-coated technology
Yuanyuan Zhang et al.
MEDCOMM (2022)
Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
Qian-Fang Meng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Engineered Nanovaccine Targeting Clec9a+ Dendritic Cells Remarkably Enhances the Cancer Immunotherapy Effects of STING Agonist
Shanshan Gou et al.
NANO LETTERS (2021)
Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy
Mei-Zhen Zou et al.
NANO LETTERS (2021)
CAR-T cell therapy: current limitations and potential strategies
Robert C. Sterner et al.
BLOOD CANCER JOURNAL (2021)
Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines
Long Chen et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
Howard Donninger et al.
VACCINES (2021)
Biomimetic cytomembrane nanovaccines prevent breast cancer development in the long term
Long Xiao et al.
NANOSCALE (2021)
Biomimetic Nanotechnology toward Personalized Vaccines
Jiarong Zhou et al.
ADVANCED MATERIALS (2020)
Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy
Dongdong Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Lang Rao et al.
ADVANCED MATERIALS (2020)
Antitumour dendritic cell vaccination in a priming and boosting approach
Alexandre Harari et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
Lang Rao et al.
NATURE COMMUNICATIONS (2020)
Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine
Qishu Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
Yuka Igarashi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fucikova et al.
CELL DEATH & DISEASE (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
Nicholas F. Kuhn et al.
CANCER CELL (2019)
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Bernardo L. Rapoport et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Immunogenic cell death in cancer therapy: Present and emerging inducers
Jingyi Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
Wen-Long Liu et al.
NATURE COMMUNICATIONS (2019)
Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy
Wei Xie et al.
ACS NANO (2019)
Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination
Rong Yang et al.
ACS NANO (2018)
Cell Membrane Coating Nanotechnology
Ronnie H. Fang et al.
ADVANCED MATERIALS (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Biointerfacing and Applications of Cell Membrane-Coated Nanoparticles
Ashley V. Kroll et al.
BIOCONJUGATE CHEMISTRY (2017)
ATP promotes the fast migration of dendritic cells through the activity of pannexin 1 channels and P2X7 receptors
Pablo J. Saez et al.
SCIENCE SIGNALING (2017)
ATP promotes the fast migration of dendritic cells through the activity of pannexin 1 channels and P2X7 receptors
Pablo J. Saez et al.
SCIENCE SIGNALING (2017)
Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity
Ashley V. Kroll et al.
ADVANCED MATERIALS (2017)
Cell membrane modulation as adjuvant in cancer therapy
Sara Zalba et al.
CANCER TREATMENT REVIEWS (2017)
Peptide/protein vaccine delivery system based on PLGA particles
Mojgan Allahyari et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes
Jing-Yi Zhu et al.
NANO LETTERS (2016)
Whole Tumor Antigen Vaccines: Where Are We?
Cheryl Lai-Lai Chiang et al.
VACCINES (2015)
Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity
Sylvain Ladoire et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang et al.
NANO LETTERS (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Cancer immunogenicity, danger signals, and DAMPs: What, when, and how?
Abhishek D. Garg et al.
BIOFACTORS (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
Yuting Ma et al.
ONCOIMMUNOLOGY (2013)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
Laetitia Aymeric et al.
CANCER RESEARCH (2010)
The immunogenicity of tumor cell death
Oliver Kepp et al.
CURRENT OPINION IN ONCOLOGY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Molecular characteristics of immunogenic cancer cell death
A. Tesniere et al.
CELL DEATH AND DIFFERENTIATION (2008)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis
H Singh-Jasuja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
